V Wealth Advisors’s ResMed RMD Stock Holding History

V Wealth Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-789	Closed	-$206K	–	471
2021 Q4	$206K	Hold	789	–	–	0.03%	429
2021 Q3	$208K	Buy	+789	New	+$216K	0.03%	442

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

V Wealth Advisors's RMD Position: Q1 2022 in Review

V Wealth Advisors sold out of ResMed (RMD) in Q1 2022, closing a stake of 789 shares — an estimated $206K sold.

V Wealth Advisors first reported a position in RMD in Q3 2021 and held it in 2 quarters. The position peaked at $208K in Q3 2021. 682 funds tracked by Wall St. Rank hold RMD as of Q1 2022.

V Wealth Advisors reported no remaining ResMed position as of Q1 2022 after selling out during the quarter.
V Wealth Advisors sold 789 ResMed shares in Q1 2022, an estimated $206K.
V Wealth Advisors first reported a position in ResMed in Q3 2021 and held it in 2 quarters.
V Wealth Advisors's ResMed position peaked at $208K in Q3 2021.
682 funds tracked by Wall St. Rank held ResMed as of Q1 2022.

Based on V Wealth Advisors's 13F filing for Q1 2022, filed 16 May 2022.